¥699.00 ($4.43)

-2.00 (-0.29%)

Weekly Expected Move ±2.4%

¥668 ¥684 ¥701 ¥718 ¥734

JPX · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 34 · ¥42.4B mcap · 16M float · 0.557% daily turnover

Revenue

$55.4B +16.7% ▲

5Y CAGR: +16.3%

Gross Profit

$11.9B +10.8% ▲

5Y CAGR: +12.6%

Operating Income

$4.2B +18.1% ▲

5Y CAGR: +15.3%

Net Income

$2.8B +17.5% ▲

5Y CAGR: +13.9%

EPS (Diluted)

$45.77 +17.5% ▲

5Y CAGR: +13.9%

EBITDA

$5.6B +24.4% ▲

5Y CAGR: +20.7%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$31.6B	$36.3B	$41.4B	$47.5B	$55.4B
YoY Growth	+21.4%	+14.6%	+14.2%	+14.7%	+16.7%
Cost of Revenue	$23.8B	$27.2B	$31.7B	$36.8B	$43.6B
Gross Profit	$7.9B	$9.0B	$9.8B	$10.7B	$11.9B
Gross Margin	24.9%	24.9%	23.5%	22.6%	21.4%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$5.1B	$5.6B	$6.1B	$7.1B	$7.7B
Operating Expenses	$5.1B	$5.6B	$6.1B	$7.1B	$7.7B
Operating Income	$2.8B	$3.4B	$3.7B	$3.6B	$4.2B
Operating Margin	8.8%	9.4%	8.8%	7.5%	7.6%
Interest Expense	$0	$739M	$0	$2M	$59M
Income Before Tax	$2.8B	$3.0B	$3.7B	$3.5B	$4.2B
Tax Expense	$913M	$953M	$1.2B	$1.2B	$1.4B
Net Income	$1.9B	$2.1B	$2.5B	$2.4B	$2.8B
Net Margin	6.0%	5.7%	6.1%	5.0%	5.0%
EPS (Diluted)	$31.49	$34.45	$41.66	$38.94	$45.77
EBITDA	$2.9B	$3.5B	$3.9B	$4.5B	$5.6B
Shares Outstanding	61M	60M	60M	60M	60M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$12.0B	$12.7B	$13.4B	$13.4B	$13.9B	$14.7B	$14.8B	$14.8B
Cost of Revenue	$9.4B	$9.9B	$10.4B	$10.6B	$11.0B	$11.5B	$11.4B	$11.5B
Gross Profit	$2.6B	$2.7B	$3.0B	$2.8B	$2.9B	$3.2B	$3.4B	$3.3B
Gross Margin	21.8%	21.5%	22.3%	20.7%	20.7%	22.0%	23.0%	22.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.8B	$1.9B	$1.8B	$1.9B	$1.9B	$2.0B	$2.0B	$2.1B
Operating Expenses	$1.8B	$1.9B	$1.8B	$1.9B	$1.9B	$2.0B	$2.0B	$2.1B
Operating Income	$806M	$846M	$1.2B	$888M	$966M	$1.2B	$1.4B	$1.2B
Operating Margin	6.7%	6.7%	8.8%	6.6%	7.0%	8.4%	9.8%	8.1%
Interest Expense	$0	$2M	$8M	$10M	$14M	$27M	$13M	$14M
Income Before Tax	$749M	$847M	$1.2B	$868M	$977M	$1.2B	$1.4B	$1.2B
Tax Expense	$242M	$325M	$374M	$288M	$308M	$385M	$471M	$388M
Net Income	$507M	$522M	$800M	$567M	$655M	$745M	$950M	$789M
Net Margin	4.2%	4.1%	6.0%	4.2%	4.7%	5.1%	6.4%	5.3%
EPS (Diluted)	$8.38	$8.64	$13.23	$9.38	$10.84	$12.32	$15.70	$13.04
EBITDA	$992M	$1.1B	$1.6B	$1.2B	$1.3B	$1.5B	$1.5B	$1.3B
Shares Outstanding	60M	60M	60M	60M	60M	60M	60M	60M

6099.T JPX